Verdict: Side-by-side breakdown using the Bull Rankings model. WY scored 68.0, EPR scored 71.0 — EPR leads.
Compare another set
WY
Weyerhaeuser Company
REIT - Specialty · Financial strength
72.2Fin
$18.97 · $13.7B
fundamentals as of
Strength gap
8.6
EPR leads
EPR
EPR Properties
REIT - Specialty · Financial strength
80.8Fin
$54.80 · $4.2B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
Fastest growthEPR+5.0%
Strongest balance sheetWY0.58
Side by side · every name on one set of axes
Fundamentals, head-to-head
WY
EPR
4.4%B+
Yield
6.8%A-
-3.1%D+
Rev
+5.0%C+
0.58A-
D/E
1.52C+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
WYWeyerhaeuser Company
REIT - Specialty · $18.97 · beta 0.93
Why now
REIT - Specialty · market cap $13.7b. Down 32% from 52-week high of $27.75 — deep drawdown territory. 11 sell-side analysts rate this a Buy with a mean 1-yr target of $28.82 (implying +52% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Down 32% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Dividend payout 129% of earnings on a 4.4% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. ROE 5% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
EPREPR Properties
REIT - Specialty · $54.80 · beta 1.02
Why now
REIT - Specialty · market cap $4.2b. 16% off the 52-week high of $64.97. 11 sell-side analysts rate this a Buy with a mean 1-yr target of $64.68 (implying +18% upside).
Moat
Net margin 36% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Dividend payout 115% of earnings on a 6.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Common questions
Is EPR or WY the better stock?
EPR scores higher: EPR 71.0, WY 68.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
How are EPR and WY scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.